TP53 and adrenal cortex carcinoma: Despite this, neither mice carrying a homolog of the human TP53 R337H mutation nor a global deletion of Trp53, the gene encoding murine p53, develop ACC [22, 23], arguing that p53 disruption alone is insufficient to induce malignant transformation in the adrenal cortex.